Searching News Database: ProStrakan Group
HSMN NewsFeed - 10 Jan 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
HSMN NewsFeed - 3 Mar 2010
Solasia Pharma and Kyowa Hakko Kirin Enter Into a License Agreement for SP-01 (Sancuso) in Asia
Solasia Pharma and Kyowa Hakko Kirin Enter Into a License Agreement for SP-01 (Sancuso) in Asia
HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
HSMN NewsFeed - 31 Jul 2008
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
HSMN NewsFeed - 25 Oct 2007
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
HSMN NewsFeed - 1 Aug 2007
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Additional items found! 13
Members Archive contains
13 additional stories matching:
ProStrakan Group
(Password required)
ProStrakan Group
(Password required)